Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:51 PM UTC
| NCT Number | NCT07129993 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE2 |
| Target Enrollment | 630 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Daiichi Sankyo |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07129993 is currently recruiting participants. This phase2 study for bladder cancer is actively seeking new participants at 38 locations across the United States. The study is sponsored by Daiichi Sankyo. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07129993 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07129993 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.